ATP-induced CA2+-signaling enhances rat gastric microvascular endothelial cell migration

Journal of Physiology and Pharmacology

Volumn 51, Issue 4, 2000, Pages 799-811

  Ehring, G R ^a,b   Szabo L L ^b   Jones, M K ^a,b   Sarfeh, L J ^b   Tarnawski, A S ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; ATP; Calcium signaling; Gastric endothelial cells; Suramin wound repair

Indexed keywords

ADENOSINE TRIPHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CALCIUM ION; CALCIUM; ENZYME INHIBITOR; PURINE RECEPTOR; SURAMIN; THAPSIGARGIN;

ANGIOGENESIS ASSAY; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL CULTURE; CELL MIGRATION ASSAY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EXTRACELLULAR CALCIUM; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HYDROLYSIS; IMAGE PROCESSING; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TEMPERATURE; WOUND HEALING; ANIMAL; CALCIUM SIGNALING; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; INJURY; INTRACELLULAR MEMBRANE; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; STOMACH; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INTRACELLULAR MEMBRANES; MICROCIRCULATION; RATS; RECEPTORS, PURINERGIC; STOMACH; SURAMIN; THAPSIGARGIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0034569950     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Folkman J, Shing Y. Angiogenesis J Biol Chem 1992; 267: 10931-10934.
2. Tarnawski A, Hollander D, Stachura J, Gergely H, Krause WJ, Sarfeh IJ. Role of angiogenesis in healing of experimental gastric ulcer. In Mechanisms of Peptic Ulcer Healing, Halter F, Garner A, Txgat TNG (eds). Dordccht/Boston/London, Kluwcr Acad Publ, 1991; pp. 165-171.
3. Guth PH, Leung FW. Physiology of the gastric circulation. In Physiology of the Gastrointestinal Tract, Johnson LR (ed). New York, Raven, 1987; pp. 1031-1054.
4. Tarnawski A, Stachura J, Hollander D, Sarfeh IJ, Bogdal J. Cellular aspects of alcohol-induced injury and prostaglandin protection of the human gastric mucosa. Focus on the mucosal microvessels. J Clin Gastroenterol 1988; 10 Suppl 1: S35-S45.
5. Jones MK, Wang H, Peskar BM, Levin E, Itani RM. Sarfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423.
6. Jones MK, Tomikawa M, Mohajer B, Tarnawski S. Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 1999; 4: D303-D309.
7. Jones MK., Itani RM, Wang FI, Tomikawa M, Sarfeh IJ, Szabo S, Tarnawski AS. Activation of VF.GF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Phvsiol 1999: 276: G1345-G1355.
8. Folkman J. Angiogcnesis and angiogenesis inhibition: an overview. Exs 1997; 79: 1-8.
9. Folkman J. Growth control in capillary endothelium. Dev Biol 1986; 3: 101-110.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
11. Folkman J, Klagsbrun M. Angiogenic factors Science 1987; 235: 442-447.
12. Derrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
13. Davis S, Yancopoulos GD. The angiopoietins: Yin and Yang in angiogenesis. Cur Top Microbiol Immunol 1999; 237: 173-185.
14. Bom GV, Kratzer MA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 1984; 354: 419-429.
15. Ralevic V, Bumstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-492.
16. Dubyak GR, cl’Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993; 265: C557-C606.
17. North RA, Barnard EA. Nucleotide receptors. Cur Opin Neurobiol 1997; 7: 346-357.
18. Gagliardi AR, Kassack M, Kreimcycr A, Muller G, Nickel P. Collins DC. Antiangiogenic and antiproliferative activity of suramin analogues Cancer Chemother Pharmacol 1998; 41: 117-124.
19. Bocci G, Dancsi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Inhibitory effect of suramin in rat modes of angiogcnesis in vitro and in vivo. Cancer Chemother Pharmacol 1999; 43: 205-212.
20. Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 1999; 58: 17-38.
21. Pescnti E, Sola F, Mongelli N, Grandi M, Spreafico F. Suramin prevents neovaseularisalion and tumour growth blocking of basic Fibroblast growth factor activity. Br J Cancer 1992; 66: 367-372.
22. Danesi R, Del Bianchi S, Soldani P, Campagni A. La Rocca RV, Myera CE, Paparelli A, Del Tacca M. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick choriallantoic membrane Br J Cancer 1993; 68: 932-938.
23. Braddock PS, Hu DE, Fan TP, Stratford IJ, Harris AL, Bicknell R. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions Br J Cancer 1994; 69: 890-798.
24. Takano S, Gately S, Neville MR, et al. Suramin, an anticancer and angiosuppressivc agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 1994; 54: 2654-2660.
25. Waltenberger J, Mayr U, Frank H, Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Moll Cell Cardiol 1996; 28: 1523-1529.
26. You J, Johnson TD, Marrclli SP, Bryan RJ. Functional heterogeneity of endothelial P2 puricoccptors in the cerebrovascular tree of the rat. Am J Physiol 1999; 277: H893-H900.
27. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J 1998; 336 (Pt 3): 513-523.
28. Jones MK, Wang H, Tomikawa M, Szabo IL, Kanawaka H, Sarfeh IJ, Tarnawski AS. Isolation and charactcrization of rat gastric microvascular endothelial cells as a model for studying gastric angiogenesis in vitro. J Physiol Pharmacol 2000; 51: 813-824.
29. Hull MA, Heweta PW, Brough JL, Hawkey CJ. Isolation and culture of human gastric endothelial cells. Gastroenterology 1996; 111: 1230-1240.
30. 2+ indicators with greally improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
31. Putney JJ. Capacitative calcium entry revisited. Cell Calcium 1990; II: 611-624.
32. Meyers KM, Holmsen H, Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol 1982; 243: R454-R461.
33. Osipchuk YV, Cahalan MD. Cell-to-cell spread of calcium signals mediated by ATP reoeptors in mast cell. Nature 1992; 359: 241-244.
34. Verghesc MW, Kneisler TB, Boucheron JA P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 1996; 271: 15597-15601
35. Burgers JA, Schweizer RC, Koenderman L, Bruijnzeel PL, Akkerman JW. Human platelets secrete chemotactic activity for eosinophils. Blood 1993; 81: 49-55.
36. McCloskey MA, Fan Y, Luther S. Chemotaxis of rat mast cells toward adenine nuclcotidcs. J Immunol 1999; 163: 970-977.
37. Satterwhitel CM, Farrelly AM, Bradley ME, Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol 1999; 276: H1091-HI097.
38. Deguchi H, Takeya H, Urano H, Gabazza EC, Zhou H, Suzuki K.. Adenosine regulates tissue factor expression on endothelial cells. Thromb Res 1998; 91: 57-64.
39. Ethier MF, Dobson JJ. Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol 1997; 272: H1470-H1479.
40. Fischer S, Kncoll E, Renz D, Karliczek GF, Schaper W. Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells [published erratum appears in Endothelium 1997; 5: 373] Endothelium 1997; 5: 155-165.
41. Li J, Fenton RA, Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JJ. Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res 1998; 80: 357-364.
42. Lutty GA, Mathews MK, Merges C, McLeod DS. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation, Curr Eye Res 1998; 17: 594-607.
43. Montesinos MC, Gadangi P, Longakcr M, et al. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 1997; 186: 1615-1620.
44. Henning RH. Purinoceptors in neuromuscular transmission. Pharmacol Ther 1997; 74: 115-128.
45. Mason JC, Yarwood H, Sugars K, Haskard DO. Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation. Am J Physiol 1997; 273: Cl233-Cl240.
46. Petzelbauer P, Bender JR, Wilson J, Pober JS. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993; 151: 5062-5072.
47. Erlingc D, Hou M, Webb TE, Bernard EA, Moeller S, Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 1998; 248: 864-870.